Risedronate Sodium
- Product NDC
- 0093-7771
- 11-digit product format
- 000937771
- Labeler code
- 0093
- Product ID
- 0093-7771_56853f43-4961-40ff-a5e8-d99b505380a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Risedronate Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA079215
- Marketing category
- ANDA
- Marketing start
- 2016-11-28
- Marketing end
- 0000-00-00
- Substance
- RISEDRONATE SODIUM MONOHYDRATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Bisphosphonate [EPC],Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-7771-13 | 00093777113 | 3 BLISTER PACK in 1 CARTON (0093-7771-13) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-7771-19) | 3 blister pack | 2016-11-28 | 0000-00-00 | No | No | Current |
| 0093-7771-79 | 00093777179 | 1 BLISTER PACK in 1 CARTON (0093-7771-79) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-7771-19) | 1 blister pack | 2016-12-12 | 0000-00-00 | No | No | Current |